Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan

Open Forum Infectious Diseases
Dana M BlythClinton K Murray

Abstract

Penetrating wounds with environmental contamination are associated with a range of infectious complications, including fungus. This is the first study to examine the epidemiology, resistance patterns, and outcomes of Candida infections and colonization in United States military patients injured in Iraq and Afghanistan. Clinical information associated with initial unique and serial Candida isolates collected from patients (June 2009-October 2013) through the Trauma Infectious Disease Outcomes Study (TIDOS) was evaluated. Susceptibilities were performed using Sensititre YeastOne (YO-9) plates and interpreted by Clinical Laboratory and Standards Institute (CLSI) and adjusted-European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. The analysis included 127 patients with 131 unique Candida isolates, of which 102 were Candida albicans and 29 non-albicans Candida spp. Overall, 99% of patients were male with a median age of 23 and an injury severity score of 22. Injuries were primarily due to blasts (77%) and sustained among personnel serving in Afghanistan (89%). There was a median of 7 days from injury to Candida isolation, and 74 isolates were associated with infection. In the multivariate analysis, non-albican...Continue Reading

References

Jan 1, 1988·The Journal of Trauma·W S CopesL W Bain
Mar 1, 1973·Archives of Environmental Health·D N GilbertJ A Barnett
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D G WolfM Shapiro
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews, UNKNOWN BSAC Working Party On Susceptibility Testing ft
Jun 6, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R KazanciogluM S Sever
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Michael A Pfaller
May 11, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Cuenca-EstrellaJ L Rodriguez-Tudela
Nov 10, 2006·Injury·Thomas A Gennarelli, Elaine Wodzin
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jan 28, 2010·Journal of Rehabilitation Research and Development·Birgitt DauMark Holodniy
Feb 26, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·Edwina C MooreHeather Cleland
May 11, 2010·The Journal of Trauma·Howard R ChampionEllen Kalin Shair
Nov 6, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M A PfallerUNKNOWN CLSI Subcommittee for Antifungal Susceptibility Testing
Dec 24, 2010·Virulence·Dimitra ManolakakiEleftherios Mylonakis
Jan 4, 2012·The American Journal of Medicine·Michael A Pfaller
Feb 4, 2012·The Pediatric Infectious Disease Journal·Gina WeddleMary Anne Jackson
May 9, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Maiken C ArendrupUNKNOWN EUCAST-AFST
Oct 9, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tyler WarkentienUNKNOWN Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group
Dec 12, 2012·The New England Journal of Medicine·Robyn Neblett FanfairBenjamin J Park
Sep 4, 2013·Journal of Infection and Public Health·Youssef FaresNadine Yared
Feb 26, 2014·Emerging Infectious Diseases·Kaitlin Benedict, Benjamin J Park
Mar 13, 2014·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maiken C ArendrupWilliam W Hope
May 14, 2014·Surgical Infections·Carlos J RodriguezDavid R Tribble

❮ Previous
Next ❯

Citations

Nov 27, 2015·Diagnostic Microbiology and Infectious Disease·Brian K WhiteUNKNOWN Infectious Disease Clinical Research Program Trauma Infectious Disease Outcome Study Group
Sep 24, 2016·Journal of Orthopaedic Trauma·Heather C YunMichael J Bosse
Nov 30, 2019·Military Medicine·Christian Coles, Martin G Ottolini
Jan 30, 2019·Diagnostic Microbiology and Infectious Disease·Katrin MendeDavid R Tribble

❮ Previous
Next ❯

Methods Mentioned

BETA
ISS

Software Mentioned

SPSS
EUCAST
SPSS Statistics

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.